Palomino Laboratories Inc.
PALX
$15.32
-$0.08-0.52%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -9.78% | -67.44% | 59.31% | -568.62% | 139.52% |
| Total Depreciation and Amortization | 346.43% | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -35.37% | 745.11% | -98.75% | 358.21% | -158.37% |
| Change in Net Operating Assets | 516.93% | 81.59% | -542.71% | -60.98% | 1,071.43% |
| Cash from Operations | -0.45% | -24.86% | -188.64% | -268.37% | -2,812.90% |
| Capital Expenditure | -195.73% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -195.73% | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -78.31% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 200.00% | 88.79% | 82.55% | -6,037.20% | -- |
| Cash from Financing | 49,603.33% | -102.68% | -82.74% | 288.19% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 973.03% | -751.31% | -96.36% | 289.24% | 51,058.06% |